Skip to content

A clinical study on Chitramutti nei in patients with low haemoglobin level

An open clinical study on paandu noi (Iron deficiency Anaemia) in children with siddha trial drug Chitramutti Nei

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/08/009553
Enrollment
40
Registered
2017-08-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Paandu Noi(Iron Deficiency Anaemia)

Interventions

Intervention1: Chitramutti Nei: Dosage of Chitramutti Nei is 4 - 5 ml twice a day duration of administration of trial drug is 28 days Control Intervention1: Nil: Nil

Sponsors

Govt siddha medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Hb level between 7 â?? 11gms 2. Sign of pallor of skin, conjunctiva, mucous membrane, nail beds 3. Anorexia, fatigue, dyspnoea on exertion, palpitation 4.Angular stomatitis 5.Loss of memory, lack of interest, frontal headache 6.Worm infestation 7.Patients who undergo routine blood investigation

Exclusion criteria

Exclusion criteria: 1.Known H/O of Metabolic disorder 2.Known H/O of Haemolytic anaemia 3.Known H/O of Thalessemia 4.Patient with chronic disease 5.Patient with any other serious illness.

Design outcomes

Primary

MeasureTime frame
Primary outcome is mainly assessed by reduction in clinical symptoms and by Raising Hb above 2g/dl and comparing the following parameters before and after treatment.Timepoint: 28 days

Secondary

MeasureTime frame
Secondary outcome is assessed by comparing the safety parameters before and after treatment.Timepoint: 28 days

Countries

India

Contacts

Public ContactDrGGKalaiselvi

Govt. siddha medical college

cspriya2004@gmail.com9444312671

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026